| UniProt ID | PTGDS_HUMAN | |
|---|---|---|
| UniProt AC | P41222 | |
| Protein Name | Prostaglandin-H2 D-isomerase | |
| Gene Name | PTGDS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 190 | |
| Subcellular Localization | Rough endoplasmic reticulum . Nucleus membrane . Golgi apparatus . Cytoplasm, perinuclear region . Secreted . Detected on rough endoplasmic reticulum of arachnoid and menigioma cells. Localized to the nuclear envelope, Golgi apparatus, secretory vesi | |
| Protein Description | Catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NREM sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophopic molecules and as a secretory retinoid and thyroid hormone transporter. Possibly involved in development and maintenance of the blood-brain, blood-retina, blood-aqueous humor and blood-testis barrier. It is likely to play important roles in both maturation and maintenance of the central nervous system and male reproductive system.. | |
| Protein Sequence | MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 29 | O-linked_Glycosylation | AAPEAQVSVQPNFQQ HCCCCEEEECCCCCC | 11.71 | 23234360 | |
| 51 | N-linked_Glycosylation | FSAGLASNSSWLREK HHHHHCCCCHHHHHH | 34.16 | 19838169 | |
| 51 | N-linked_Glycosylation | FSAGLASNSSWLREK HHHHHCCCCHHHHHH | 34.16 | 19838169 | |
| 53 | Phosphorylation | AGLASNSSWLREKKA HHHCCCCHHHHHHHH | 34.09 | 24719451 | |
| 78 | N-linked_Glycosylation | PATDGGLNLTSTFLR CCCCCCCCHHHHHHH | 44.54 | 22171320 | |
| 78 | N-linked_Glycosylation | PATDGGLNLTSTFLR CCCCCCCCHHHHHHH | 44.54 | 22171320 | |
| 93 | Phosphorylation | KNQCETRTMLLQPAG HCCCCCCEEEEEECC | 21.42 | 23663014 | |
| 101 | Phosphorylation | MLLQPAGSLGSYSYR EEEEECCCCCCCEEC | 31.50 | 23663014 | |
| 104 | Phosphorylation | QPAGSLGSYSYRSPH EECCCCCCCEECCCC | 19.05 | 23663014 | |
| 105 | Phosphorylation | PAGSLGSYSYRSPHW ECCCCCCCEECCCCC | 14.13 | 23663014 | |
| 106 | Phosphorylation | AGSLGSYSYRSPHWG CCCCCCCEECCCCCC | 18.77 | 24719451 | |
| 107 | Phosphorylation | GSLGSYSYRSPHWGS CCCCCCEECCCCCCC | 13.58 | 23663014 | |
| 147 | Phosphorylation | GEDFRMATLYSRTQT CHHCHHHHHHCCCCC | 19.52 | 24043423 | |
| 149 | Phosphorylation | DFRMATLYSRTQTPR HCHHHHHHCCCCCCC | 7.55 | 18083107 | |
| 150 | Phosphorylation | FRMATLYSRTQTPRA CHHHHHHCCCCCCCH | 31.78 | 24043423 | |
| 152 | Phosphorylation | MATLYSRTQTPRAEL HHHHHCCCCCCCHHH | 30.74 | 24043423 | |
| 154 | Phosphorylation | TLYSRTQTPRAELKE HHHCCCCCCCHHHHH | 17.71 | 24043423 | |
| 173 | Phosphorylation | FCKAQGFTEDTIVFL HHHHCCCCCCEEEEE | 39.51 | 25072903 | |
| 176 | Phosphorylation | AQGFTEDTIVFLPQT HCCCCCCEEEEECCC | 16.89 | 25072903 | |
| 183 | Phosphorylation | TIVFLPQTDKCMTEQ EEEEECCCCCCCCCC | 35.17 | 25072903 | |
| 188 | Phosphorylation | PQTDKCMTEQ----- CCCCCCCCCC----- | 40.48 | 25072903 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTGDS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTGDS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTGDS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PTGDS_HUMAN | PTGDS | physical | 12627223 | |
| HRSL4_HUMAN | RARRES3 | physical | 22960220 | |
| HXK2_RAT | Hk2 | physical | 11068878 | |
| HXK3_RAT | Hk3 | physical | 11068878 | |
| PD2R_HUMAN | PTGDR | physical | 24493589 | |
| HS90A_HUMAN | HSP90AA1 | physical | 24493589 | |
| KR107_HUMAN | KRTAP10-7 | physical | 25416956 | |
| KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
| ARRB2_HUMAN | ARRB2 | physical | 21112970 | |
| CHIO_HUMAN | CHN2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-78, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY. | |
| "Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51 AND ASN-78, STRUCTUREOF CARBOHYDRATES, AND MASS SPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51, AND MASS SPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78, AND MASS SPECTROMETRY. | |
| "Purification and chemical characterization of beta-trace protein fromhuman cerebrospinal fluid: its identification as prostaglandin Dsynthase."; Hoffmann A., Conradt H.S., Gross G., Nimtz M., Lottspeich F.,Wurster U.; J. Neurochem. 61:451-456(1993). Cited for: PROTEIN SEQUENCE OF 23-190, AND GLYCOSYLATION AT ASN-51 AND ASN-78. | |